Description

This exchange-traded fund (ETF) aims to deliver twice the daily performance of its benchmark index, which is composed of North American cannabis companies weighted by their market capitalization. The index constituents include businesses involved in cannabis production or supply, biotechnology firms conducting cannabinoid research and development, or entities that primarily invest within the cannabis sector. Given its leveraged design, this fund is not suitable for buy-and-hold strategies, and its magnified returns should not be anticipated to extend beyond a single day.